Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors (Q34079116)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors |
scientific article |
Statements
1 reference
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors (English)
1 reference
Joseph H Antin
1 reference
Jerome Ritz
1 reference
John Koreth
1 reference
Kristen E Stevenson
1 reference
Haesook T Kim
1 reference
Michael Garcia
1 reference
Vincent T Ho
1 reference
Philippe Armand
1 reference
Corey Cutler
1 reference
Robert J Soiffer
1 reference
Edwin P Alyea
1 reference
27 August 2009
1 reference
1 reference
114
1 reference
18
1 reference
3956-3959
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference